New cholesterol guidelines aim to stop heart disease earlier
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 10-Jun-2026 17:16 ET (10-Jun-2026 21:16 GMT/UTC)
Researchers have developed a novel mouse model that replicates severe geleophysic dysplasia, including short stature, heart valve alterations, and early lethality—characteristics of this rare disease. The findings from the study in The American Journal of Pathology, published by Elsevier, provide a basis for the identification of molecular mechanisms underlying geleophysic dysplasia, which can then be targeted for therapeutic purposes.
Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research. The findings may encourage doctors to more actively address cardiovascular health in patients before they become pregnant.
In a new paper, scientists of the Earth Commission argue how today’s scenarios are falling short of providing solutions to the climate crisis. They call for a rethink that puts justice, diverse knowledge, and systemic change at the heart of modelling.
Atherosclerotic cardiovascular disease remains one of the world’s leading drivers of heart attacks and ischemic strokes, largely because fatty, inflamed plaques can build up inside arteries and eventually rupture. In a new comprehensive review published ahead-of-print in Current Drug Therapy, physician-researcher Francisco Epelde synthesizes evidence showing that modern pharmacologic care is increasingly moving beyond “slowing progression” toward an ambitious but measurable goal: reducing plaque size and transforming plaque composition into a more stable, less rupture-prone form.